All ArticlesClinical TrialsClinical Trials: Questions to Ask Your DoctorMedically Reviewed: Richard J. Lin, MD, PhDThe decision to enroll in a clinical trial is one you should make thoughtfully and with the help of your cancer care team. Clinical TrialsClinical Trials: Questions to Ask Your DoctorMedically Reviewed: Richard J. Lin, MD, PhDThe decision to enroll in a clinical trial is one you should make thoughtfully and with the help of your cancer care team. Clinical TrialsDoctors Salute Bravery of Clinical Trial PatientsAt the 2024 ASCO Annual Meeting, researchers express their gratitude for patients participating in clinical trials. Clinical TrialsDoctors Salute Bravery of Clinical Trial PatientsAt the 2024 ASCO Annual Meeting, researchers express their gratitude for patients participating in clinical trials. Prostate CancerProstate Cancer: When to Consider a Clinical TrialAn expert discusses when a prostate cancer patient should consider a clinical trial and how working with an academic center can increase options. Prostate CancerProstate Cancer: When to Consider a Clinical TrialAn expert discusses when a prostate cancer patient should consider a clinical trial and how working with an academic center can increase options. Myeloproliferative NeoplasmsMy 5th Year MANIFEST Trial AnniversaryMedically Reviewed: Thomas LeBlanc, M.D., M.A., MHS, FAAHPM, FASCONed Weinshenker, a patient with primary myelofibrosis, reflects on the fifth anniversary of his MANIFEST clinical trial participation. Myeloproliferative NeoplasmsMy 5th Year MANIFEST Trial AnniversaryMedically Reviewed: Thomas LeBlanc, M.D., M.A., MHS, FAAHPM, FASCONed Weinshenker, a patient with primary myelofibrosis, reflects on the fifth anniversary of his MANIFEST clinical trial participation. Chronic Lymphocytic LeukemiaWhen Will I Feel Better On My CLL Clinical Trial?A Patient Power user with chronic lymphocytic leukemia who is on a clinical trial wondered when she will feel better. Our expert responded. Chronic Lymphocytic LeukemiaWhen Will I Feel Better On My CLL Clinical Trial?A Patient Power user with chronic lymphocytic leukemia who is on a clinical trial wondered when she will feel better. Our expert responded. Clinical TrialsMinimizing Toxicity in Abstracts May Harm CareMedically Reviewed: Mayur Narkhede, MDDescribing treatment toxicities using minimizing language may harm care, according to a review of abstracts from three major oncology/hematology conferences. Clinical TrialsMinimizing Toxicity in Abstracts May Harm CareMedically Reviewed: Mayur Narkhede, MDDescribing treatment toxicities using minimizing language may harm care, according to a review of abstracts from three major oncology/hematology conferences. Navigating CancerThe Hidden Costs of Clinical TrialsMedically Reviewed: Kerry Rogers, MDThere are ways to find financial support if you or a loved one are considering a clinical trial. Navigating CancerThe Hidden Costs of Clinical TrialsMedically Reviewed: Kerry Rogers, MDThere are ways to find financial support if you or a loved one are considering a clinical trial. Myeloproliferative NeoplasmsOnward and Upward: Living with Primary MyelofibrosisMedically Reviewed: Thomas LeBlanc, M.D., M.A., MHS, FAAHPM, FASCOA patient with primary myelofibrosis (PMF) provides an update on his progress on the MANIFEST clinical trial. Myeloproliferative NeoplasmsOnward and Upward: Living with Primary MyelofibrosisMedically Reviewed: Thomas LeBlanc, M.D., M.A., MHS, FAAHPM, FASCOA patient with primary myelofibrosis (PMF) provides an update on his progress on the MANIFEST clinical trial. Chronic Lymphocytic LeukemiaThe Lifecycle of a Clinical TrialClear up any confusion about clinical trials by learning about its lifecycle. Chronic Lymphocytic LeukemiaThe Lifecycle of a Clinical TrialClear up any confusion about clinical trials by learning about its lifecycle. Myeloproliferative NeoplasmsJAK Inhibitors May Improve Myelofibrosis Survival RateClinical trials are advancing what we know about JAK inhibitors and myelofibrosis. Learn more. Myeloproliferative NeoplasmsJAK Inhibitors May Improve Myelofibrosis Survival RateClinical trials are advancing what we know about JAK inhibitors and myelofibrosis. Learn more. Lung CancerThree Clinical Trials Focus on Second-Line Lung Cancer TreatmentsLearn about three clinical trials highlighted at ASCO 2022 that could improve second-line treatment options for lung cancer. Lung CancerThree Clinical Trials Focus on Second-Line Lung Cancer TreatmentsLearn about three clinical trials highlighted at ASCO 2022 that could improve second-line treatment options for lung cancer. Systemic MastocytosisPatient Perspective: A Clinical Trial Success StorySystemic mastocytosis patient Kathi Jo Chappell shares how her quality of life has improved since joining a new clinical trial. Systemic MastocytosisPatient Perspective: A Clinical Trial Success StorySystemic mastocytosis patient Kathi Jo Chappell shares how her quality of life has improved since joining a new clinical trial.
